PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

New orphan drug designation, page-14

  1. 2,129 Posts.
    lightbulb Created with Sketch. 569
    Probably a lot more. There’s active National Societies of MPS in Oz and the US.

    its a very connected network with annual conferences in Orlando for families and big day to day support networks. PPS and Paradigm’s efforts have already been circulated amongst the community.

    I can recall a study done that showed PPS helps normal skeletal (spine & skull), and aorta development if applied early enough in juveniles in animal studies. It was a dramatic difference.

    We have a real shot at making a huge difference to that community. Target pharmaceutical companies for partnership would be Biomatin and Sanofi, if any. Such a targeted, well connected community would require little sales effort.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.0¢ 25.0¢ 23.0¢ $211.2K 895.4K

Buyers (Bids)

No. Vol. Price($)
4 82174 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 49300 8
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.